Clinical Ophthalmology.
People Policies Reception of articles Other

Role of probiotics in the treatment and prevention of genitourinary infections

Abstract

DOI: 10.32364/2618-8430-2025-8-2-5

M.S. Selikhova

Volgograd State Medical University, Volgograd, Russian Federation

Urinary tract infections (UTIs) represent one of the leading causes of gynecological morbidity and their incidence shows no significant downward trend. A characteristic feature concerning the clinical manifestation of inflammatory diseases in recent years has been a predominantly chronic course, frequently accompanied by relapses. While novel antibacterial agents have demonstrated efficacy in the management of acute infections, their efficacy is markedly reduced in cases of chronic UTIs and they are insufficient in preventing relapse. Over the past 10–15 years, there has been a profound shift in research focus toward the study of the female reproductive tract microbiome, with particular attention to vaginal microbiocenosis, given its relevance to the ascending route of infection to the upper genital tract. The adjunctive use of probiotics following antimicrobial therapy is currently regarded as a promising therapeutic strategy. Evidence suggests that, in cases of complicated vulvovaginal candidiasis, the administration of probiotic preparations as a second-line intervention following antimycotic therapy can reduce relapse rates by up to twofold. Moreover, prophylactic probiotic administration in immunocompromised women contributes to the maintenance of normal vaginal microbiocenosis and preservation of the vaginal barrier function. At present, the therapeutic armamentarium includes a novel multifunctional probiotic complex consisting of a unique combination of probiotic strains (Bifidobacterium longum BL21, Lactobacillus crispatus LCr, Lactobacillus gasseri LG08, Lactobacillus jensenii LJe52) and prebiotic components that optimize the environment for microflora normalization, thereby facilitating restoration of sufficient lactobacilli populations during the second phase of vaginal infection therapy. In addition, each capsule of this symbiotic formulation contains D-mannose and cranberry powder, which contributes to the prevention of dysuric symptoms and supports the overall health of the female urinary tract.

Keywords: vaginal microbiocenosis, bacterial vaginosis, candidal vulvovaginitis, chronic course, relapses, two-stage treatment, lactobacilli, symbiotic.

For citation: Selikhova M.S. Role of probiotics in the treatment and prevention of genitourinary infections. Russian Journal of Woman and Child Health. 2025;8(2):124–127 (in Russ.). DOI: 10.32364/2618-8430-2025-8-2-5

ABOUT THE AUTHOR:

Marina S. Selikhova — Dr. Sc. (Med.), Professor of the Department of Obstetrics and Gynecology, Volgograd State Medical University; 1, Pavshikh Bortsov sq., Volgograd, 400131, Russian Federation; ORCID iD 0000-0002-4393-6111

Contact information: Marina S. Selikhova, e-mail: selichovamarina@yandex.ru

Financial Disclosure: the author has no financial or property interest in any material or method mentioned.

There is no conflict of interest.

Received 19.02.2025.

Revised 14.03.2025.

Accepted 08.04.2025.

References
1. Савельева Г.М. Гинекология / под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова, В.Е. Радзинского, И.Б. Манухина. М.: ГЭОТАР-Медиа; 2017.Savelyeva G.M. Gynecology / ed. By G.M. Savelyev, G.T. Sukhikh, V.N. Serov, V.E. Radzinsky, I.B. Manukhin. M.: GEOTAR-Media; 2017 (in Russ.). 2. Евдокимова Н.В., Черненькая Т.В. Микробиом кишечника человека: научная парадигма и клиническая практика. Патологическая физиология и экспериментальная терапия. 2024;68(2):76–86. DOI: 10.25557/0031-2991.2024.02.76-86Evdokimova N.V., Chernenkaya T.V. Human intestinal microbiome: scientific paradigm and clinical practice. Pathological physiology and experimental therapy. 2024;68(2):76–86 (in Russ.). DOI: 10.25557/0031-2991.2024.02.76-86 3. Perez-Muñoz M.E, Arrieta M.-C., Ramer-Tait A.E., Walter J. Acritical assessment of the "sterile womb" and "in utero colonization" hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5(1):48. DOI: 10.1186/s40168-017-0268-4 4. Ross J., Guaschino S., Cusini M., Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018;29(2):108–114. DOI: 10.1177/0956462417744099 5. Franasiak J.M., Scott R.T.Jr. Reproductive tract microbiome in assisted reproductive technologies. Fertil Steril. 2015;104(6):1364–1371. DOI: 10.1016/j.fertnstert.2015.10.012 6. Verstraelen H., Vilchez-Vargas R., Desimpel F. et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ. 2016;4:e1602. DOI: 10.7717/peerj.1602 7. Роговская С.И., Касян В.Н., Бриль Ю.А. Решение не окончательное, обжалованию подлежит. Есть ли место эмпирической терапии вагинальных инфекций? StatusPraesens. Гинекология, акушерство, бесплодный брак. 2020;1(64):61–68.Rogovskaya S.I., Kasyan V.N., Bril Yu.A. The decision is not final and is subject to appeal. Is there a place for empirical therapy of vaginal infections? StatusPraesens. Gynecology, obstetrics, infertile marriage. 2020;1(64):61–68 (in Russ.). 8. Нургалиева Е.В., Духин А.О., Гущин А.Е. Микробиота женских половых органов при гнойно-воспалительных заболеваниях гениталий. Вестник Российского университета дружбы народов. Серия: Медицина. 2016;2:197–201.Nurgalieva E.V., Dukhin A.O., Gushchin A.E. Microbiota of female genital organs in purulent-inflammatory diseases of the genitals. Bulletin of Peoples' Friendship University of Russia. Series: Medicine. 2016;2:197–201 (in Russ.). 9. Romero R., Hassan S.S., Gajer P. et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4. DOI: 10.1186/2049-2618-2-4 10. Казанцева В.Д., Озолиня Л.А., Савченко Т.Н., Доброхотова Ю.Э. Современные стратегии лечения и профилактики бактериального вагиноза. РМЖ. Мать и дитя. 2025;8(1):27–31. DOI: 10.32364/2618-8430-2025-8-1-4Kazantseva V.D., Ozolinya L.A., Savchenko T.N., Dobrokhotova Yu.E. Modern treatment tactics and prophylaxis of bacterial vaginosis. Russian Journal of Woman and Child Health. 2025;8(1):27–31 (in Russ.). DOI: 10.32364/2618-8430-2025-8-1-4 11. Российское общество акушеров-гинекологов. Клинические рекомендации по диа­гностики и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин (издание 2-е, исп. и доп.). М.; 2019.Russian Society of Obstetricians and Gynecologists. Clinical guidelines for the diagnosis and treatment of diseases accompanied by pathological discharge from the female genital tract (2nd edition, revised and supplemented) M.; 2019 (in Russ.). 12. Willems H.M.E., Ahmed S.S., Liu J. et al. Vulvovaginal Candidiasis: A Current Understanding and Burning Questions. J Fungi (Basel). 2020;6(1):27. DOI: 10.3390/jof6010027 13. Denning D.W., Kneale M., Sobel J.D., Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: A systematic review. Lancet Infect Dis. 2018;18:e339–e347. DOI: 10.1016/S1473-3099(18)30103-8 14. Paavonen J.A., Brunham R.C. Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin Number 215. Obstet Gynecol. 2020;135(5):1229–1230. DOI: 10.1097/AOG.0000000000003857 15. Workowski K.A., Bachmann L.H., Chan P.A. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. DOI: 10.15585/mmwr.rr7004a1 16. Hillier S.L., Austin M., Macio I. et al. Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings. Clin Infect Dis. 2021;72(9):1538–1543. DOI: 10.1093/cid/ciaa260 17. Радзинский В.Е., Хамошина М.Б. Результаты многоцентрового наблюдательного исследования: терапия острого вагинита неспе­ци­фической и смешанной этиологии у пациенток репродуктивного возраста. Акушерство и гинекология. 2019;(8):150–158. DOI: 10.18565/aig.2019.8.150-158Radzinsky V.E., Khamoshina M.B. Results of a multicenter observational study: therapy for acute vaginitis of nonspecific and mixed etiology in patients of reproductive age. Obstetrics and Gynecology. 2019;(8):150–158 (in Russ.). DOI: 10.18565/aig.2019.8.150-158 18. Obiero J., Rulisa S., Ogongo P., Wiysonge C.S. Nifuratel-Nystatin combination for the treatment of mixed infections of bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis. Cochrane Database Syst Rev. 2018;2018(4):CD013012. DOI: 10.1002/14651858.CD013012 19. Sobel J.D., Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opin Pharmacother. 2018;19(9):971–977. DOI: 10.1080/14656566.2018.1476490 20. Lewis F.M.T., Bernstein K.T., Aral S.O. Vaginal Microbiome and Its Relationship to Behavior, Sexual Health, and Sexually Transmitted Diseases. Obstet Gynecol. 2017;129(4):643–654. DOI: 10.1097/AOG.0000000000001932 21. Greenbaum S., Greenbaum G., Moran-Gilad J. et al. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019;220(4):324–335. DOI: 10.1016/j.ajog.2018.11.1089 22. Torcia M.G. Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections. Int J Mol Sci. 2019;20(2):266. DOI: 10.3390/ijms20020266 23. Senok A.C., Verstraelen H., Temmerman M., Botta G.A. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev. 2009;(4):CD006289. DOI: 10.1002/14651858.CD006289 24. Huang H., Song L., Zhao W. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch Gynecol Obstet. 2014;289(6):1225–1234. DOI: 10.1007/s00404 013-3117-0 25. Riepl M. Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome. Int J Pharm Compd. 2018;22(6):456–465. PMID: 30384345. 26. Gupta P., Singh M.P., Goyal K. Diversity of Vaginal Microbiome in Pregnancy: Deciphering the Obscurity. Front Public Health. 2020;8:326. DOI: 10.3389/fpubh.2020.00326 27. De Vrese M., Laue C., Papazova E. et al. Impact of oral administration of four Lactobacillus strains on Nugent score — systematic review and meta-analysis. Benef Microbes. 2019;10(5):483–496. DOI: 10.3920/BM2018.0129 28. Bohbot J.M., Daraï E., Bretelle F. et al. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod. 2018;47(2):81–86. DOI: 10.1016/j.jogoh.2017.11.005 29. Fu Z., Liska D., Talan D., Chung M. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J Nutr. 2017;147(12):2282–2288. DOI: 10.3945/jn.117.254961 30. DE Leo V., Cappelli V., Massaro M.G. et al. [Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina® and D-mannose in recurrent urinary infections in perimenopausal women]. Minerva Ginecol. 2017;69(4):336–341 (in Italian). DOI: 10.23736/S0026-4784.17.04074-6 31. Громова О.А., Торшин И.Ю. О перспективах применения лактобактериальных пробиотиков, D-маннозы и экстрактов клюквы в терапии инфекций мочевыводящих путей. Акушерство, Гинекология и Репродукция. 2023;17(4):485–499. DOI: 10.17749/2313-7347/ob.gyn.rep.2023.442Gromova O.A., Torshin I.Yu. Regarding the prospects of using Lactobacillus-based probiotics, D-mannose and cranberry extracts in therapy of urinary tract infections. Obstetrics, Gynecology and Reproduction. 2023;17(4):485–499 (in Russ.). DOI: 10.17749/2313-7347/ob.gyn.rep.2023.442 32. Леонова М.В. Пробиотики в лечении вагинальных инфекций: эффективность с позиции доказательной медицины. Медицинский совет. 2020;(13):148–154. DOI: 10.21518/2079-701X-2020-13-148-154Leonova M.V. Probiotics in the treatment of vaginal infections: efficacy from the perspective of evidence-based medicine. Medical сouncil. 2020;(13):148–154 (in Russ.). DOI: 10.21518/2079-701X-2020-13-148-154

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Read the article in PDF in Russian


Previous article
Next article
Review of clinical studies on the use of...
0
1797
Successful organ-preserving surgical tre...
0
2153
All articles

Распечатать